📷 Image: Wikimedia Commons / Sricitysez
Local
Explosion at Pharma Plant Near Sri City, Tirupati Kills 2, Injures 12
✍️ The Times of India
🗓 03 Oct 2026, 01:32 PM
👁 19
An explosion ripped through a pharmaceutical manufacturing unit near Sri City, close to Tirupati, leaving two people dead and twelve injured, officials said.
A sudden blast erupted at a pharmaceutical factory located on the outskirts of Sri City, near Tirupati in Andhra Pradesh, killing two workers and wounding twelve others, according to local authorities.
Emergency response teams, including fire services and medical personnel, arrived promptly at the scene, evacuating the injured to nearby hospitals for treatment. The injured have been reported to be in stable condition, though some remain under observation for possible injuries related to the explosion.
The cause of the explosion is yet to be determined. Police and the factory's safety committee have launched an investigation to ascertain whether equipment failure, handling of chemicals, or other factors triggered the incident.
Authorities have cordoned off the area to facilitate forensic analysis and to ensure public safety. The factory, which produces generic medicines for domestic distribution, has temporarily halted operations pending the outcome of the inquiry.
The incident underscores the need for stringent safety protocols in industrial zones, especially those handling hazardous substances, officials added.
Emergency response teams, including fire services and medical personnel, arrived promptly at the scene, evacuating the injured to nearby hospitals for treatment. The injured have been reported to be in stable condition, though some remain under observation for possible injuries related to the explosion.
The cause of the explosion is yet to be determined. Police and the factory's safety committee have launched an investigation to ascertain whether equipment failure, handling of chemicals, or other factors triggered the incident.
Authorities have cordoned off the area to facilitate forensic analysis and to ensure public safety. The factory, which produces generic medicines for domestic distribution, has temporarily halted operations pending the outcome of the inquiry.
The incident underscores the need for stringent safety protocols in industrial zones, especially those handling hazardous substances, officials added.